A question of how, not if

President’s Forward for Research and Development in China

China is set to accelerate innovation in drugs and medical devices

The effects of adopting international pharmaceutical standards

A new opportunity for European business

      IP Protection in the Pharmaceutical Industry

The European Chamber has long advocated for the interests of European SMEs in China. In the EU they are important sources of employment – over the past five years, SMEs have created around 85 per cent of new jobs and provided two-thirds of total private…

What’s the biggest impediment to business these days? Lack of capital? Skill shortages? Overcapacity? Regulation?

Innovation and entrepreneurship have become the key driving forces of China’s supply-side reform.

Does censorship, defined as the suppression and restriction of communication and the flow of information, hamper innovation?